Trial Identifier: | D8850C00006 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05281601 |
Start Date: | March 2022 |
Primary Completion Date: | April 2024 |
Study Completion Date: | April 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
BE | Bruxelles, BE, 1200 |
BE | Leuven, BE, 3000 |
BR | Belo Horizonte, BR, 30130-100 |
BR | Botucatu, BR, 18610-070 |
BR | Porto Alegre, BR, 90035-001 |
DE | Frankfurt am Main, DE, 60590 |
DE | Köln, DE, 50924 |
ES | Esplugues de Llobregat (Barc), ES, 08950 |
ES | Madrid, ES, 28041 |
GB | Edinburgh, GB, EH9 1LF |
GB | Leeds, GB, LS1 3EX |
GB | London, GB, SW17 0RE |
GB | London, GB, W2 1NY |
GB | Manchester, GB, M13 9WL |
GB | Newcastle-upon-Tyne, GB, NE1 4LP |
GB | Southampton, GB, SO16 6YD |
MX | Mérida, MX, 97070 |
MX | Mexico, MX, 14000 |
UA | Dnipro, UA, 49006 |
UA | Dnipropetrovsk, UA, 49100 |
UA | Krivoi Rog, UA, 49006 |
UA | Zaporizhzhia, UA, 69076 |
US, CA | Long Beach, CA, US, 90806 |
US, CA | Los Angeles, CA, US, 90095 |
US, CA | Stanford, CA, US, 94305 |
US, CO | Aurora, CO, US, 80045 |
US, DC | Washington, DC, US, 20007 |
US, FL | Miami, FL, US, 33155 |
US, FL | Saint Petersburg, FL, US, 33701 |
US, ID | Idaho Falls, ID, US, 83404 |
US, MI | Ann Arbor, MI, US, 48109 |
US, MO | Kansas City, MO, US, 64108 |
US, NY | Stony Brook, NY, US, 11794 |
US, RI | Providence, RI, US, 02903 |
US, SC | Mount Pleasant, SC, US, 29464 |